Although the primary targets of activated isoniazid (INH) are proteins invo
lved in the biosynthesis of cell wall mycolic acids, clinical resistance is
dominated by specific point mutations in katG. Mutations associated with t
arget mutations contribute to, but still cannot completely explain, resista
nce ro INH. Despite the wealth of genetic information currently available,
the molecular mechanism of cell death induced by INH remains elusive. (C) 2
000 Editions scientifiques et medicales Elsevier SAS.